US 11548947
Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11548947 (Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/57, A61P